NVCR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.29%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $61,749.10

NovoCure Insider Trading History Chart

NovoCure Share Price & Price History

^$18.86

▼ -0.11 (-0.58%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

NovoCure Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/1/2024	Frank X Leonard	EVP	Sell	598	$15.94	$9,532.12	161,236
11/1/2024	Mukund Paravasthu	COO	Sell	160	$15.88	$2,540.80	3,503
10/31/2024	Michael Nath Puri	Insider	Sell	810	$15.79	$12,789.90	110,093
8/2/2024	Ashley Cordova	CFO	Sell	688	$20.14	$13,856.32	219,179
6/4/2024	William Anthony Vernon	Director	Sell	964	$23.89	$23,029.96	164,833
3/4/2024	Frank X Leonard	EVP	Sell	840	$16.01	$13,448.40	160,098
3/4/2024	Wilhelmus Cm Groenhuysen	COO	Sell	1,217	$16.01	$19,484.17	251,235
3/1/2024	Frank X Leonard	EVP	Sell	1,679	$16.03	$26,914.37	160,938
3/1/2024	Wilhelmus Cm Groenhuysen	COO	Sell	2,107	$16.03	$33,775.21	252,452
2/28/2024	Frank X Leonard	EVP	Sell	2,078	$16.14	$33,538.92	162,617
11/7/2023	Pritesh Shah	Insider	Sell	382	$12.65	$4,832.30	124,511
9/1/2023	Ashley Cordova	CFO	Sell	883	$21.82	$19,267.06	99,650
9/1/2023	Pritesh Shah	Insider	Sell	273	$21.82	$5,956.86	124,893
9/1/2023	Wilhelmus Cm Groenhuysen	COO	Sell	294	$21.82	$6,415.08	209,825
3/3/2023	Frank X Leonard	Insider	Sell	2,059	$77.64	$159,860.76	67,893
3/1/2023	Ashley Cordova	CFO	Sell	2,198	$76.36	$167,839.28	96,062
3/1/2023	Frank X Leonard	Insider	Sell	1,684	$76.36	$128,590.24	63,095
3/1/2023	Wilhelmus Cm Groenhuysen	COO	Sell	2,164	$76.36	$165,243.04	184,615
1/5/2023	Asaf Danziger	CEO	Sell	212,500	$108.74	$23,107,250.00	13,583
1/5/2023	Uri Weinberg	Insider	Sell	8,143	$116.14	$945,728.02	43,286
10/13/2022	Frank X Leonard	Insider	Sell	6,754	$76.01	$513,371.54	43,626
10/6/2022	Frank X Leonard	Insider	Sell	6,754	$84.37	$569,834.98	50,380
9/29/2022	Frank X Leonard	Insider	Sell	6,754	$77.35	$522,421.90	57,134
9/22/2022	Frank X Leonard	Insider	Sell	6,754	$77.00	$520,058.00	63,888
9/15/2022	Frank X Leonard	Insider	Sell	12,271	$88.52	$1,086,228.92	70,642
9/9/2022	Frank X Leonard	Insider	Sell	1,863	$88.00	$163,944.00	84,150
8/2/2022	Ely Benaim	Insider	Sell	437	$69.66	$30,441.42	34,631
8/2/2022	William F. Doyle	Chairman	Sell	837	$69.66	$58,305.42	551,176
6/10/2022	Jeryl L. Hilleman	Director	Sell	407	$69.61	$28,331.27	2,537

See Full Table

SEC Filings (Institutional Ownership Changes) for NovoCure (NASDAQ:NVCR)

84.61% of NovoCure stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

NovoCure Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/18/2025	California State Teachers Retirement System	96,389	$2.87M	0.0%	-0.7%	0.088%
2/20/2025	Mackenzie Financial Corp	6,820	$0.20M	0.0%	N/A	0.006%
2/19/2025	GF Fund Management CO. LTD.	2,272	$68K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	701,645	$20.91M	0.0%	-22.7%	0.648%
2/17/2025	Voloridge Investment Management LLC	870,155	$25.93M	0.1%	-15.4%	0.804%
2/17/2025	Soleus Capital Management L.P.	2,739,704	$81.64M	5.1%	N/A	2.532%
2/17/2025	Two Sigma Advisers LP	586,000	$17.46M	0.0%	-39.2%	0.542%
2/17/2025	Two Sigma Investments LP	561,120	$16.72M	0.0%	-24.2%	0.519%
2/17/2025	Tidal Investments LLC	46,160	$1.38M	0.0%	-17.2%	0.043%
2/17/2025	Teza Capital Management LLC	100,200	$2.99M	0.5%	+573.0%	0.093%
2/17/2025	Silvercrest Asset Management Group LLC	348,307	$10.38M	0.1%	-29.8%	0.322%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	6,901	$0.21M	0.1%	+264.6%	0.006%
2/17/2025	ProShare Advisors LLC	35,115	$1.05M	0.0%	+32.4%	0.032%
2/17/2025	Quantinno Capital Management LP	294,639	$8.78M	0.1%	+17.1%	0.272%
2/17/2025	Nuveen Asset Management LLC	358,952	$10.70M	0.0%	-1.5%	0.332%
2/17/2025	Millennium Management LLC	735,227	$21.91M	0.0%	+28.8%	0.680%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	72,490	$2.16M	0.0%	+2.8%	0.067%
2/17/2025	LMR Partners LLP	32,914	$0.98M	0.0%	N/A	0.030%
2/17/2025	Graham Capital Management L.P.	21,709	$0.65M	0.0%	-59.0%	0.020%
2/17/2025	Focus Partners Wealth	92,872	$2.77M	0.0%	-2.7%	0.086%
2/17/2025	Frontier Capital Management Co. LLC	726,324	$21.64M	0.2%	-16.7%	0.671%
2/17/2025	Deutsche Bank AG	194,327	$5.79M	0.0%	+20.7%	0.180%
2/17/2025	Corton Capital Inc.	12,709	$0.38M	0.2%	-10.9%	0.012%
2/17/2025	Cubist Systematic Strategies LLC	335,218	$9.99M	0.1%	+223.1%	0.310%
2/17/2025	Balyasny Asset Management L.P.	1,068,863	$31.85M	0.0%	+27.4%	0.988%
2/17/2025	BNP Paribas Financial Markets	28,555	$0.85M	0.0%	-83.8%	0.026%
2/17/2025	Ameriprise Financial Inc.	22,883	$0.68M	0.0%	+77.7%	0.021%
2/17/2025	Algert Global LLC	69,261	$2.06M	0.0%	N/A	0.064%
2/14/2025	PDT Partners LLC	80,232	$2.39M	0.2%	-28.4%	0.074%
2/14/2025	Schonfeld Strategic Advisors LLC	105,280	$3.14M	0.0%	N/A	0.097%
2/14/2025	Emerald Mutual Fund Advisers Trust	325,255	$9.69M	0.6%	N/A	0.301%
2/14/2025	Northern Trust Corp	1,284,350	$38.27M	0.0%	+39.1%	1.187%
2/14/2025	The Manufacturers Life Insurance Company	152,602	$4.55M	0.0%	-24.5%	0.141%
2/14/2025	Birchview Capital LP	31,000	$0.92M	0.7%	+55.0%	0.029%
2/14/2025	Adage Capital Partners GP L.L.C.	200,000	$5.96M	0.0%	N/A	0.185%
2/14/2025	T. Rowe Price Investment Management Inc.	1,690,441	$50.38M	0.0%	-39.8%	1.562%
2/14/2025	Price T Rowe Associates Inc. MD	1,683,818	$50.18M	0.0%	-27.5%	1.556%
2/14/2025	Hsbc Holdings PLC	49,725	$1.50M	0.0%	-15.4%	0.046%
2/14/2025	Tower Research Capital LLC TRC	2,034	$61K	0.0%	-76.6%	0.002%
2/14/2025	MetLife Investment Management LLC	65,319	$1.95M	0.0%	+6.0%	0.060%
2/14/2025	Dimensional Fund Advisors LP	25,753	$0.77M	0.0%	-10.5%	0.024%
2/14/2025	Capital World Investors	4,815,529	$143.50M	0.0%	+11.8%	4.451%
2/14/2025	GeoWealth Management LLC	901	$27K	0.0%	N/A	0.001%
2/14/2025	Capital International Investors	8,873,902	$264.44M	0.0%	+12.0%	8.201%
2/13/2025	Canada Pension Plan Investment Board	8,000	$0.24M	0.0%	-40.3%	0.007%
2/13/2025	Marshall Wace LLP	270,952	$8.07M	0.0%	-65.2%	0.250%
2/13/2025	EAM Investors LLC	141,893	$4.23M	0.6%	N/A	0.131%
2/13/2025	Jump Financial LLC	176,252	$5.25M	0.1%	+28.5%	0.163%
2/13/2025	Bridgewater Associates LP	11,119	$0.33M	0.0%	-71.8%	0.010%
2/13/2025	XTX Topco Ltd	14,395	$0.43M	0.0%	N/A	0.013%
2/13/2025	Mariner LLC	8,631	$0.26M	0.0%	N/A	0.008%
2/13/2025	Summit Investment Advisors Inc.	11,141	$0.33M	0.3%	+6.8%	0.010%
2/13/2025	Granite Investment Partners LLC	686,727	$20.46M	0.9%	N/A	0.635%
2/13/2025	F M Investments LLC	32,100	$0.96M	0.0%	N/A	0.030%
2/13/2025	Raymond James Financial Inc.	11,672	$0.35M	0.0%	N/A	0.011%
2/13/2025	Renaissance Technologies LLC	734,354	$21.88M	0.0%	-1.3%	0.679%
2/13/2025	Legal & General Group Plc	157,758	$4.70M	0.0%	-14.5%	0.146%
2/13/2025	Invesco Ltd.	189,474	$5.65M	0.0%	+72.6%	0.175%
2/13/2025	Bank of Montreal Can	8,183	$0.24M	0.0%	N/A	0.008%
2/13/2025	Polymer Capital Management US LLC	6,989	$0.21M	0.1%	N/A	0.006%
2/13/2025	FMR LLC	16,230,139	$483.66M	0.0%	0.0%	15.000%
2/13/2025	Federated Hermes Inc.	907,987	$27.08M	0.1%	-9.0%	0.839%
2/13/2025	Russell Investments Group Ltd.	1,158	$35K	0.0%	-64.8%	0.001%
2/13/2025	Envestnet Asset Management Inc.	9,159	$0.27M	0.0%	N/A	0.008%
2/12/2025	Cinctive Capital Management LP	109,812	$3.27M	0.2%	N/A	0.101%
2/12/2025	Geode Capital Management LLC	2,400,182	$71.54M	0.0%	-0.2%	2.218%
2/12/2025	Franklin Resources Inc.	156,064	$4.65M	0.0%	-13.7%	0.144%
2/12/2025	Pictet Asset Management Holding SA	14,919	$0.45M	0.0%	+19.8%	0.014%
2/11/2025	TIAA Trust National Association	8,035	$0.24M	0.0%	N/A	0.007%
2/11/2025	Prudential Financial Inc.	7,170	$0.21M	0.0%	N/A	0.007%
2/11/2025	Corebridge Financial Inc.	52,946	$1.58M	0.0%	-7.0%	0.049%
2/11/2025	Emerald Advisers LLC	547,557	$16.32M	0.6%	N/A	0.506%
2/11/2025	Vanguard Group Inc.	11,796,109	$351.52M	0.0%	-0.4%	10.902%
2/11/2025	LPL Financial LLC	27,861	$0.83M	0.0%	N/A	0.026%
2/11/2025	KLP Kapitalforvaltning AS	21,600	$0.64M	0.0%	N/A	0.020%
2/11/2025	Semanteon Capital Management LP	13,276	$0.40M	0.2%	-82.0%	0.012%
2/11/2025	Teacher Retirement System of Texas	59,252	$1.77M	0.0%	N/A	0.055%
2/11/2025	Xponance Inc.	7,762	$0.23M	0.0%	N/A	0.007%
2/10/2025	Thrivent Financial for Lutherans	26,003	$0.78M	0.0%	-28.7%	0.024%
2/10/2025	Counterpoint Mutual Funds LLC	24,892	$0.74M	0.1%	-14.9%	0.023%
2/10/2025	Cibc World Markets Corp	9,966	$0.30M	0.0%	N/A	0.009%
2/10/2025	Swiss National Bank	202,200	$6.03M	0.0%	+1.3%	0.187%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	437,772	$13.05M	0.1%	+2.7%	0.405%
2/7/2025	Zurcher Kantonalbank Zurich Cantonalbank	27,385	$0.82M	0.0%	+21.0%	0.025%
2/7/2025	Essex Investment Management Co. LLC	121,826	$3.63M	0.7%	-24.8%	0.113%
2/7/2025	Nordwand Advisors LLC	312,155	$9.30M	3.8%	-89.7%	0.288%
2/6/2025	Lindbrook Capital LLC	1,854	$55K	0.0%	+189.2%	0.002%
2/6/2025	Raymond James Financial Inc.	11,672	$0.35M	0.0%	N/A	0.011%
2/6/2025	Proficio Capital Partners LLC	30,158	$0.90M	0.0%	N/A	0.028%
2/6/2025	M&T Bank Corp	12,384	$0.37M	0.0%	-3.6%	0.011%
2/6/2025	Charles Schwab Investment Management Inc.	836,214	$24.92M	0.0%	+1.4%	0.773%
2/6/2025	SBI Securities Co. Ltd.	2,341	$70K	0.0%	N/A	0.002%
2/5/2025	Proficio Capital Partners LLC	30,158	$0.90M	0.0%	N/A	0.028%
2/5/2025	Taylor Frigon Capital Management LLC	143,442	$4.28M	2.2%	-10.4%	0.133%
2/4/2025	Los Angeles Capital Management LLC	70,601	$2.10M	0.0%	+362.4%	0.065%
2/4/2025	Bank of New York Mellon Corp	322,530	$9.61M	0.0%	+3.2%	0.298%
2/4/2025	Y Intercept Hong Kong Ltd	18,769	$0.56M	0.0%	N/A	0.017%
2/4/2025	C WorldWide Group Holding A S	621,784	$18.53M	0.2%	+19.2%	0.575%
2/3/2025	Handelsbanken Fonder AB	37,523	$1.12M	0.0%	+9.6%	0.035%
1/31/2025	New York State Common Retirement Fund	99,595	$2.97M	0.0%	+201.9%	0.092%

Data available starting January 2016

See Full Table

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Today's Range

Now: $18.86

$18.41

$18.93

50 Day Range

MA: $21.72

$18.19

$27.02

52 Week Range

Now: $18.86

$11.70

$34.13

Volume

640,312 shs

Average Volume

1,204,157 shs

Market Capitalization

$2.07 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63

Who are the company insiders with the largest holdings of NovoCure?: NovoCure's top insider investors include:
Wilhelmus Cm Groenhuysen (COO)
Ashley Cordova (CFO)
W Anthony Vernon (Director)
Frank X Leonard (EVP)
Pritesh Shah (Insider)
Michal Nath Puri (Insider)
Mukund Paravasthu (COO)
Learn More about top insider investors at NovoCure.
Who are the major institutional investors of NovoCure?: NovoCure's top institutional shareholders include:
FMR LLC — 15.00%
Vanguard Group Inc. — 10.90%
Capital International Investors — 8.20%
Capital World Investors — 4.45%
Soleus Capital Management L.P. — 2.53%
Geode Capital Management LLC — 2.22%
Learn More about top institutional investors of NovoCure stock.
Which major investors are selling NovoCure stock?: In the last quarter, NVCR stock was sold by these institutional investors:
Nordwand Advisors LLC
T. Rowe Price Investment Management Inc.
Price T Rowe Associates Inc. MD
Marshall Wace LLP
Baillie Gifford & Co.
Two Sigma Advisers LP
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Two Sigma Investments LP
Within the last year, company insiders that have sold NovoCure company stock include:
Wilhelmus Cm Groenhuysen (COO)
Ashley Cordova (CFO)
W Anthony Vernon (Director)
Frank X Leonard (EVP)
Pritesh Shah (Insider)
Learn More investors selling NovoCure stock.
Which major investors are buying NovoCure stock?: In the last quarter, NVCR stock was acquired by institutional investors including:
Soleus Capital Management L.P.
Capital International Investors
Granite Investment Partners LLC
Emerald Advisers LLC
Capital World Investors
Northern Trust Corp
Emerald Mutual Fund Advisers Trust
Cubist Systematic Strategies LLC